Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM.

Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010. Erratum in: Cancer Cell. 2013 Apr 15;23(4):557.

PMID:
21575865
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ETS fusion genes in prostate cancer.

Gasi Tandefelt D, Boormans J, Hermans K, Trapman J.

Endocr Relat Cancer. 2014 May 6;21(3):R143-52. doi: 10.1530/ERC-13-0390. Print 2014 Jun. Review.

PMID:
24659477
[PubMed - indexed for MEDLINE]
Free Article
3.

Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.

Zhang J.

Asian J Androl. 2014 May-Jun;16(3):401-6. doi: 10.4103/1008-682X.123684. Review.

PMID:
24589464
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer].

Guo XQ, Gui YT, Cai ZM.

Yi Chuan. 2011 Feb;33(2):117-22. Review. Chinese.

PMID:
21377967
[PubMed - indexed for MEDLINE]
5.

[TMPRSS2-ETS gene fusion in prostate cancer].

Perner S, Schmidt FH, Hofer MD, Kuefer R, Rubin M.

Urologe A. 2007 Jul;46(7):754-60. Review. German.

PMID:
17458530
[PubMed - indexed for MEDLINE]
6.

ETS gene fusions in prostate cancer.

Clark JP, Cooper CS.

Nat Rev Urol. 2009 Aug;6(8):429-39. doi: 10.1038/nrurol.2009.127. Review.

PMID:
19657377
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk